Product Information
METRONIDAZOLE TOPICAL 1% GEL is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $0.6210 per GM under NDC 00713057460. Its NADAC has been published 175 times since May 31, 2023.
FDA first approved this application on Jan 23, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/g
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713057460
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA216692FDA Approved
1/23/2023
TE Code
AB
On Market Since
2/1/2023
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE TOPICAL 1% GEL has been published 175 times since May 31, 2023, and over the history we have for it it has declined 41.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6210 per GM |
|---|---|
| All-time high | $1.0579 (Jun 14, 2023) |
| All-time low | $0.5951 (May 22, 2024) |
| 52-week high | $0.8011 |
| 52-week low | $0.6209 |
| Median price | $0.7849 |
| Average price | $0.7839 |
| Largest weekly change | +38.7% (Jun 19, 2024) |
| Weeks tracked | 175 |
| Tracking since | May 31, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cosette Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
metronidazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitroimidazole Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE TOPICAL 1% GEL?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE TOPICAL 1% GEL, manufactured by Cosette Pharmaceuticals, Inc., is $0.6210 per GM (NDC 00713057460), effective Sep 30, 2026.
How has the price of METRONIDAZOLE TOPICAL 1% GEL changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE TOPICAL 1% GEL has declined 41.3%. It has been tracked across 175 weekly CMS publications since May 31, 2023.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE TOPICAL 1% GEL?
Since May 31, 2023, the NADAC for METRONIDAZOLE TOPICAL 1% GEL has ranged from a low of $0.5951 (May 22, 2024) to a high of $1.0579 (Jun 14, 2023), with a median of $0.7849 per GM.
Are there cheaper alternatives to METRONIDAZOLE TOPICAL 1% GEL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METRONIDAZOLE TOP 1% GEL PUMP, is $0.5399 per GM — about 13% below METRONIDAZOLE TOPICAL 1% GEL.
Who manufactures METRONIDAZOLE TOPICAL 1% GEL?
METRONIDAZOLE TOPICAL 1% GEL (NDC 00713057460) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a generic product.